In contrast, agents used in treating T2DM such as biguanides, thiazolidinediones, and glucagon-like peptide-1 receptor (GLP-1) agonists have been noted to be advantageous in combating psoriasis lesions as well [41]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.